Evidence map›Paper›PMID 36484919›Full record

ArticleInsights into imaging2022

AI in breast screening mammography: breast screening readers' perspectives.

Clarisse Florence de Vries, Samantha J Colosimo, Moragh Boyle, Gerald Lip, Lesley A Anderson, Roger T Staff, iCAIRD Radiology Collaboration

Abstract read
In one paragraph

Article in Insights into imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Artificial Intelligence in Radiology: A Leadership Survey.Journal of the American College of Radiology : JACR · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Breast cancer detection accuracy of AI in an entire screening population: a retrospective, multicentre study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Clarisse Florence de VriesAberdeen Centre for Health Data Science, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland. clarisse.devries@abdn.ac.uk.ORCID http://orcid.org/0000-0002-9616-4231
Samantha J ColosimoAberdeen Royal Infirmary, National Health Service Grampian (NHSG), Aberdeen, Scotland.
Moragh BoyleAberdeen Centre for Health Data Science, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland.
Gerald LipAberdeen Royal Infirmary, National Health Service Grampian (NHSG), Aberdeen, Scotland.
Lesley A AndersonAberdeen Centre for Health Data Science, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland.
Roger T StaffAberdeen Royal Infirmary, National Health Service Grampian (NHSG), Aberdeen, Scotland.
iCAIRD Radiology Collaboration

Funding

Innovate UK 104690
6 · The paper itself

Abstract

objectivesThis study surveyed the views of breast screening readers in the UK on how to incorporate Artificial Intelligence (AI) technology into breast screening mammography.

methodsAn online questionnaire was circulated to the UK breast screening readers. Questions included their degree of approval of four AI implementation scenarios: AI as triage, AI as a companion reader/reader aid, AI replacing one of the initial two readers, and AI replacing all readers. They were also asked to rank five AI representation options (discrete opinion; mammographic scoring; percentage score with 100% indicating malignancy; region of suspicion; heat map) and indicate which evidence they considered necessary to support the implementation of AI into their practice among six options offered.

resultsThe survey had 87 nationally accredited respondents across the UK; 73 completed the survey in full. Respondents approved of AI replacing one of the initial two human readers and objected to AI replacing all human readers. Participants were divided on AI as triage and AI as a reader companion. A region of suspicion superimposed on the image was the preferred AI representation option. Most screen readers considered national guidelines (77%), studies using a nationally representative dataset (65%) and independent prospective studies (60%) as essential evidence. Participants' free-text comments highlighted concerns and the need for additional validation.

conclusionsOverall, screen readers supported the introduction of AI as a partial replacement of human readers and preferred a graphical indication of the suspected tumour area, with further evidence and national guidelines considered crucial prior to implementation.

Indexed as

Breast screening readerMammographyRadiologistScreeningSurvey

Identifiers

PMID36484919
PMCPMC9733732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.